Uncategorized
Glaukos reports 57% increase in net sales in third quarter
Glaukos reported $19 million in net sales in the third quarter, a 57% increase from $12.1 million reported in the same quarter of 2014, according to a press release. The increase was attributed to the continued adoption of the iStent trabecular micro-bypass stent.